CardioWise

Website

CardioWise, Inc.

0 Investors
HealthTech, Medical Software
FAYETTEVILLE, AR

CardioWise, Inc. is a medical technology company that provides a non-invasive solution for cardiac diagnostics. It has developed a cloud-based software platform that uses artificial intelligence to analyze standard cardiac CT scans, generating a detailed 4D model of heart function to aid in the early detection and management of heart disease.

Products & Team

SQuEEZ™ (Stretch Quantifier for Endocardial Engraved Zones)

Cardiac Diagnostic SoftwareSeed

SQuEEZ™ is a cloud-based Software as a Service (SaaS) platform that utilizes machine learning to analyze cardiac CT images. Physicians can upload scans to a secure portal and receive a detailed, 4D strain analysis of the patient's heart in under 10 minutes, presented as an easy-to-interpret color model representing the health of the heart muscle.

Value Proposition

SQuEEZ™ addresses the need for a faster, more efficient, and comprehensive diagnostic tool for heart disease. It aims to become a new gold standard by shortening the time to diagnosis, reducing the need for multiple tests, and providing objective data to guide treatment planning and monitoring.

Pain Points

The technology addresses the limitations of traditional cardiac imaging, which often relies on qualitative assessments, requires long diagnosis turnaround times of 24-48 hours, and may involve multiple, separate scans to achieve a complete picture of heart health.

Provides objective, quantitative data on heart functionDisplays analysis in an easy-to-interpret 4D color modelPerforms analysis using non-invasive cardiac CT scansOperates on a cloud-based SaaS model for easy workflow integration without new equipment
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
FAYETTEVILLE, AR
Primary headquarters

Funding History

0
E

Equity Offering

September 2025
$3.0M
Target
Progress
0%
Raised
$0
Target
$3.0M
#000201668725000001